SARCOPENIC OBESITY IN PATIENTS RECEIVING TREATMENT WITH PROGRAMMED HEMODIALYSIS
- 23 June 2022
- journal article
- research article
- Published by Non-profit organization Nephrology in Nephrology (Saint-Petersburg)
- Vol. 26 (2) , 77-84
Abstract
САРКОПЕНИЧЕСКОЕ ОЖИРЕНИЕ У БОЛЬНЫХ, ПОЛУЧАЮЩИХ ЛЕЧЕНИЕ ПРОГРАММНЫМ ГЕМОДИАЛИЗОМKeywords
This publication has 9 references indexed in Scilit:
- Diagnosis, prevalence, and mortality of sarcopenia in dialysis patients: a systematic review and meta‐analysisJournal of Cachexia, Sarcopenia and Muscle, 2022
- Obesity diagnostics in patients with hemodialysis: bioimpedansometry and caliperometryNephrology (Saint-Petersburg), 2021
- Bed-side measures for diagnosis of low muscle mass, sarcopenia, obesity, and sarcopenic obesity in patients with chronic kidney disease under non-dialysis-dependent, dialysis dependent and kidney transplant therapyPLOS ONE, 2020
- Sarcopenia: revised European consensus on definition and diagnosisAge and Ageing, 2019
- Sarcopenic Obesity Definitions by Body Composition and Mortality in the Hemodialysis PatientsJournal of Renal Nutrition, 2017
- Obesity and Heart Failure: Focus on the Obesity ParadoxMayo Clinic Proceedings, 2017
- Lean Tissue ImagingJournal of Parenteral and Enteral Nutrition, 2014
- Body Composition in Healthy AgingAnnals of the New York Academy of Sciences, 2000
- Sarcopenia: Origins and Clinical RelevanceThe Journal of Nutrition, 1997